Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2017-04-05
Original market date: See footnote 1
1993-10-29
Lot number: See footnote 2
UH536AB
Expiry date: See footnote 2
2015-08-27
Product name:
MENOMUNE-A/C/Y/W-135
DIN:
01959018
Product Monograph/Veterinary Labelling:
Date:
2013-07-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SANOFI PASTEUR LIMITED
1755 Steeles Avenue West
Toronto
Ontario
Canada
M2R 3T4
Class:
Human
Dosage form(s):
Powder For Solution , Kit
Route(s) of administration:
Subcutaneous
Number of active ingredient(s):
4
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
80:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
J07AH04 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN
Active ingredient group (AIG) number:See footnote5
0440084002
| Active ingredient(s) | Strength |
|---|---|
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A | 50 MCG / 0.5 ML |
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C | 50 MCG / 0.5 ML |
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 | 50 MCG / 0.5 ML |
| MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y | 50 MCG / 0.5 ML |